Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Pharma Foods’Antibody Technology Advances as Takeda Exercises Sequence Purchase Option
Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants
[Summary]Consolidated Financial Results for the Nine Months Ended April 30, 2025 (Under Japanese GAAP)
Supplementary Materials of Consolidated Financial Results for the Nine Months Ended April 30, 2025
Notice Concerning Results of Acquisition of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)
Notice Concerning Acquisition of Own Shares and Repurchase of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)
Supplementary Materials of Consolidated Financial Results for the Six Months Ended January 31, 2025
(Delayed)Summary of Consolidated Financial Results for the Six Months Ended January 31, 2025 (Based on Japanese GAAP)
The establishment of World's first "CADASIL Drug Discovery Research Department" in collaboration with National Cerebral and Cardiovascular Center
(Delayed)Summary of Consolidated Financial Results for the Three Months Ended October 31, 2024 (Based on Japanese GAAP)
(Delayed) Summary of Consolidated Financial Results for the Year Ended July 31, 2024 (Based on Japanese GAAP)